Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors (BiPAVE-001)
Clinical Trial Grant
Awarded By
OncoC4, Inc.
Start Date
February 17, 2026
End Date
February 15, 2031
Awarded By
OncoC4, Inc.
Start Date
February 17, 2026
End Date
February 15, 2031